CompoAtlas

Gélules de graine de nigelle d'Ethiopie

Food supplement declared in France, decision dated 20 May 2026

Gélules de graine de nigelle d'Ethiopie (Mielomad) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Nigella sativa 1,000 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Mielomad
Food business operator placing the product on the market
Mielomad
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2
Directions for use
Mode d’emploi : Prendre 2 à 4 gélules par jour avec un grand verre d’eau, de préférence au cours des repas. Conservation : Conserver dans un endroit sec, à l’abri de la chaleur et de la lumière. Précautions d’emploi : Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des enfants. Les compléments alimentaires ne remplacent pas une alimentation variée et équilibrée ainsi qu’un mode de vie sain.
Intended populations
General population, Adolescents aged 11 to 17, Men and women aged 18 and over, People over 60, Men, Women, Women planning pregnancy
Not recommended (according to the manufacturer)
Breastfeeding women, Young children (aged 1 to 3), Pregnant women, Kidney disease, Infants (under 1 year), Liver problems, Taking anticoagulants, Taking diabetes medication, Children (under 6)
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Bowel regularity, Joints, Respiratory tract, Digestion, Immunity, Slimming / Blood sugar, Skin, Sport
Flavourings
non

Declaration 365316, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Nigella sativa L.SeedPowder (dried or ground plant)1,000 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. Déconseillé aux femmes enceintes ou allaitantes ainsi qu’aux enfants. Demander conseil à un professionnel de santé avant utilisation en cas de traitement médicamenteux (notamment anticoagulants, antidiabétiques ou antihypertenseurs) ou de pathologie chronique. Tenir hors de portée des jeunes enfants. Les compléments alimentaires ne se substituent pas à une alimentation variée et équilibrée ni à un mode de vie sain. Conserver dans un endroit sec, à l’abri de la chaleur et de la lumière.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Mielomad

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Gélules de graine de nigelle d'Ethiopie (Mielomad): composition and regulation”, https://compoatlas.com/en/supplements/products/365316-gelules-de-graine-de-nigelle-d-ethiopie, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line